G
The startup operates a diagnostic platform that utilizes next-generation sequencing to develop tests for accurately characterizing cancers such as non-Hodgkin lymphomas and sarcomas. This technology enables medical professionals to achieve faster diagnoses, ultimately enhancing patient care and treatment outcomes.
Updated 4 months ago
Funding
$810K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup operates a diagnostic platform that utilizes next-generation sequencing to develop tests for accurately characterizing cancers such as non-Hodgkin lymphomas and sarcomas. This technology enables medical professionals to achieve faster diagnoses, ultimately enhancing patient care and treatment outcomes.